Arcturus Therapeutics (ARCT) News Today → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free ARCT Stock Alerts $27.12 -0.09 (-0.33%) (As of 01:08 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights:finance.yahoo.com - May 9 at 7:58 AMArcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights: ...finance.yahoo.com - May 9 at 7:58 AMArcturus Therapeutics Holdings First Quarter 2024 Earnings: Beats Expectationsfinance.yahoo.com - May 9 at 7:58 AMARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 8 at 11:08 PMArcturus Therapeutics: Q1 Earnings Snapshotsfgate.com - May 8 at 9:57 PMArcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progressfinance.yahoo.com - May 8 at 9:57 PMArcturus Therapeutics (NASDAQ:ARCT) Trading Down 6.1%marketbeat.com - May 2 at 6:56 PMArcturus Therapeutics (ARCT) Scheduled to Post Earnings on Wednesdaymarketbeat.com - May 1 at 8:55 AMArcturus Therapeutics Holdings' (NASDAQ:ARCT) investors will be pleased with their impressive 284% return over the last five yearsfinance.yahoo.com - April 29 at 11:01 AMArcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024businesswire.com - April 25 at 4:01 PMArcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosisseekingalpha.com - April 23 at 12:31 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.marketbeat.com - April 20 at 5:49 AMArcturus Therapeutics (NASDAQ:ARCT) Trading Down 3.2%marketbeat.com - April 17 at 11:58 AMArcturus Therapeutics (NASDAQ:ARCT) Trading Up 3.4%marketbeat.com - April 16 at 3:23 PMAnalysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and 23andMe Holding (ME)markets.businessinsider.com - April 16 at 1:57 AMShort Interest in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Rises By 14.3%marketbeat.com - April 14 at 9:39 AMVanguard Group Inc. Sells 221,573 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - April 11 at 4:11 AMAlnylam Pharma Earns Buy Rating on Robust Clinical Trials and Strategic Partnershipsmarkets.businessinsider.com - April 9 at 3:53 PMArcturus Therapeutics Holdings, Inc.cnn.com - April 6 at 11:46 PMArcturus Therapeutics (NASDAQ:ARCT) Shares Down 3.3% marketbeat.com - April 4 at 5:28 PMBuy Rating Affirmed for Arcturus: Promising Vaccine Commercialization and Rare Disease Pipeline Progressmarkets.businessinsider.com - April 1 at 5:51 PMSG Americas Securities LLC Trims Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - March 31 at 4:16 AMIntravacc B.V.: Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Developmentfinanznachrichten.de - March 29 at 8:42 AMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells $610,573.70 in Stockinsidertrades.com - March 28 at 8:25 AMARK Investment Management LLC Acquires 146,141 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - March 28 at 6:39 AMArcturus Therapeutics Holdings Inc (ARCT) Insider Sells Sharesfinance.yahoo.com - March 28 at 2:28 AMOptimistic Buy Rating for Arcturus Therapeutics Amid Strong Kostaive Vaccine Market Prospects in Japanmarkets.businessinsider.com - March 27 at 10:10 AMArcturus Therapeutics (NASDAQ:ARCT) Trading Down 6.5%marketbeat.com - March 26 at 4:22 PMInsider Selling: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells 8,565 Shares of Stockinsidertrades.com - March 22 at 10:02 AMArcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...finance.yahoo.com - March 22 at 2:11 AMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells $299,860.65 in Stockmarketbeat.com - March 21 at 7:57 PMArcturus Therapeutics' (ARCT) "Buy" Rating Reiterated at HC Wainwrightmarketbeat.com - March 20 at 8:11 AMArcturus Therapeutics (NASDAQ:ARCT) Shares Up 3%marketbeat.com - March 19 at 11:59 AMArcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 5.3%marketbeat.com - March 18 at 12:44 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Short Interest Down 6.6% in Februarymarketbeat.com - March 18 at 11:24 AMArcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 17 at 2:09 PMARCT Apr 2024 30.000 callca.finance.yahoo.com - March 16 at 9:56 AMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Purchased by AQR Capital Management LLCmarketbeat.com - March 13 at 4:33 AMThe Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Expertsmarkets.businessinsider.com - March 11 at 12:01 PMAnalysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)markets.businessinsider.com - March 11 at 6:59 AMArcturus Therapeutics Holdings Inc. (ARCT) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 9 at 8:35 PMAnalysts Offer Insights on Healthcare Companies: Cigna (CI) and Arcturus Therapeutics (ARCT)markets.businessinsider.com - March 8 at 1:29 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 1:29 PMWilliam Blair Reiterates Outperform Rating for Arcturus Therapeutics (NASDAQ:ARCT)marketbeat.com - March 8 at 11:23 AMQ4 2023 Arcturus Therapeutics Holdings Inc Earnings Callfinance.yahoo.com - March 8 at 8:29 AMQube Research & Technologies Ltd Has $3.97 Million Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - March 8 at 5:43 AMArcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developmentsfinance.yahoo.com - March 8 at 1:45 AMARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 7 at 11:06 PMRecap: Arcturus Therapeutics Q4 Earningsbenzinga.com - March 7 at 8:45 PMArcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progressbusinesswire.com - March 7 at 4:01 PM Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career… Click For My #1 FREE Crypto for 2024 ARCT Media Mentions By Week ARCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARCT News Sentiment▼-0.140.36▲Average Medical News Sentiment ARCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARCT Articles This Week▼83▲ARCT Articles Average Week Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Evolus News Phibro Animal Health News Bicycle Therapeutics News Disc Medicine News Y-mAbs Therapeutics News AnaptysBio News Pliant Therapeutics News Silence Therapeutics News Nuvation Bio News Praxis Precision Medicines News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARCT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
